首页> 外文期刊>AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences >Side-hole catheter placement for hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer: long-term treatment and survival benefit.
【24h】

Side-hole catheter placement for hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer: long-term treatment and survival benefit.

机译:大肠癌肝转移患者肝动脉灌注化疗的侧孔导管置入:长期治疗和生存获益。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The objective of this study was to evaluate retrospectively correlations between catheter placement methods and treatment outcomes of patients treated with hepatic arterial infusion chemotherapy for unresectable liver metastases from colorectal cancer. MATERIALS AND METHODS: This study involved 135 patients with liver metastases from colorectal cancer who underwent intrahepatic chemotherapy using catheter-port systems. Complications, treatment discontinuation, hepatic progression, and survival of patients treated with each method were evaluated retrospectively using the Kaplan-Meier method. Conventional 5-French end-hole catheter placement (n = 10) was compared with three side-hole catheter placement methods: 5-French side-hole catheter placement with a fixed catheter tip (original fixed catheter tip method, n = 77); long tapered side-hole catheter placement using a fixed catheter tip method (modified fixed catheter tip method, n = 24); and long tapered side-hole catheter inserted distally in the hepatic artery (long tapered catheter placement method, n = 24). RESULTS: The following treatment outcomes were significantly better for patients treated using the original or modified fixed catheter tip or long tapered catheter placement method than for those treated using the conventional method, respectively: hepatic arterial patency (1 year: 76.3%, 95.0%, and 94.4% vs 38.9%; p = 0.0014, 0.0007, and 0.0006), catheter stability (1 year: 96.7%, 95.5%, and 95.2% vs 42.9%; p < 0.0001, p = 0.0003, and p = 0.0009), time to treatment discontinuation (medians: 11.7, 14.4, and 12.4 vs 3.2 months; p < 0.0001, 0.0002, and 0.0019), time to hepatic progression (medians: 14.7, 15.7, and 15.8 vs 5.5 months; p = 0.0049, 0.0141, and 0.0004), and overall survival (medians: 21.1, 22.5, and 23.1 vs 13.1 months; p = 0.0146, 0.0036, and 0.0017). CONCLUSION: Compared with the conventional method, side-hole catheter placement methods allowed long-term intrahepatic chemotherapy and resulted in improved survival.
机译:目的:本研究的目的是回顾性评估导管置入方法与肝动脉灌注化疗治疗无法切除的大肠癌肝转移患者的治疗结果之间的相关性。材料与方法:本研究涉及135例大肠癌肝转移患者,他们使用导管端口系统进行了肝内化疗。使用Kaplan-Meier方法回顾性评估了用每种方法治疗的患者的并发症,治疗中止,肝进展和生存率。将传统的5法式端孔导管置入法(n = 10)与三种侧孔法置管方法进行了比较:使用固定导管尖端的5法式侧孔导管置入法(原始固定导管尖端法,n = 77);使用固定导管尖端方法(改良的固定导管尖端方法,n = 24)进行长锥形侧孔导管放置;并在肝动脉远端插入长锥形侧孔导管(长锥形导管放置方法,n = 24)。结果:使用原始或改良的固定导管尖端或长锥形导管置入方法治疗的患者的以下治疗结果分别明显优于使用传统方法的患者:肝动脉通畅性(1年:76.3%,95.0%,和94.4%vs 38.9%; p = 0.0014、0.0007和0.0006),导管稳定性(1年:96.7%,95.5%和95.2%vs 42.9%; p <0.0001,p = 0.0003,p = 0.0009),停药时间(中位数:11.7、14.4和12.4 vs 3.2个月; p <0.0001、0.0002和0.0019),肝病进展时间(中位数:14.7、15.7和15.8 vs 5.5个月; p = 0.0049、0.0141,和0.0004),以及总体生存率(中位数:21.1、22.5和23.1与13.1个月; p = 0.0146、0.0036和0.0017)。结论:与常规方法相比,侧孔导管置入方法可进行长期肝内化疗并提高生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号